Impressum / Imprint & legal notice

The METAcancer internal website is provided by the METAcancer consortium partner

tp21 GmbH

Tuerkenstrasse 4
D-66111 Saarbruecken

Tel:  +49 (0)681 390 6718
Fax: +49 (0)681 390 6720


Vertretungsberechtigte Geschaeftsfuehrer (CEOs): Dr. Petra Zalud / Dr. Hanno Wittig

Registergericht (registered at): Amtsgericht Saarbruecken
Registernummer: HRB 13818

Umsatzsteueridentifikationsnummer gemaess § 27a Umsatzsteuergesetz (VAT-number): DE 229 548 135

notice of liability

Despite careful control, we cannot assume any liability for the content of the linked pages. The owners of the respective linked-to pages are solely liable for the contents.


The information on this website is provided as is and no guarantee or warranty is given that the information is fit for particular purpose. The user thereof uses the information at its sole risk and liability.
The Collaborative Project METAcancer has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° HEALTH-F2-2008-200327. Neither the European Commission nor any person acting behalf of the Commission is responsible for the use which might be made of the information provided on this website.

Published by the METAcancer project consortium. All rights reserved. Reproduction only with permission of the publishers.

Breaking News:

18.02.2016 09:25

Medicines for rare diseases

Legal background to the procedure for orphan designation in the EU

News Archive